| # | Drug | Count |
|---|---|---|
| 0 | DOCETAXEL | 11 |
| 1 | DOCETAXEL ANHYDROUS | 11 |
| 2 | CANDESARTAN CILEXETIL | 10 |
| 3 | METFORMIN | 10 |
| 4 | METFORMIN ER 500 MG | 10 |
| 5 | METFORMIN ER 750 MG | 10 |
| 6 | CARBOPLATIN | 9 |
| 7 | CLONAZEPAM | 9 |
| 8 | MINOCYCLINE HYDROCHLORIDE | 9 |
| 9 | VENLAFAXINE HYDROCHLORIDE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COCAINE HYDROCHLORIDE NASAL | 1 | 0.0154 |
| 1 | CARBON DIOXIDE | 1 | 0.0087 |
| 2 | PALIFERMIN | 1 | 0.0026 |
| 3 | CISATRACURIUM BESYLATE | 4 | 0.0018 |
| 4 | CHLOROQUINE PHOSPHATE | 1 | 0.0015 |
| 5 | MINOCYCLINE HYDROCHLORIDE | 9 | 0.0015 |
| 6 | NITROUS OXIDE | 2 | 0.0009 |
| 7 | PHENELZINE SULFATE | 1 | 0.0006 |
| 8 | BAYER ASPIRIN EXTRA STRENGTH | 2 | 0.0005 |
| 9 | FLUVASTATIN SODIUM | 2 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 13 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 2 | Corticosteroid [EPC] | 11 |
| 3 | Microtubule Inhibitor [EPC] | 11 |
| 4 | Platinum-based Drug [EPC] | 9 |
| 5 | HER2/neu Receptor Antagonist [EPC] | 8 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 8 |
| 7 | Alkylating Drug [EPC] | 6 |
| 8 | Loop Diuretic [EPC] | 6 |
| 9 | Provitamin D2 Compound [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 4 | 0.0002 |
| 2 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 3 | 0.0002 |
| 3 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 4 | Osmotic Diuretic [EPC] | 1 | 0.0002 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 6 | Alkaloid [EPC] | 4 | 0.0002 |
| 7 | General Anesthetic [EPC] | 5 | 0.0001 |
| 8 | Interleukin-17A Antagonist [EPC] | 4 | 0.0001 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 8 | 0.0001 |